- Home
- PHX vs LXEO Comparison
PHX vs LXEO Comparison
Compare PHX & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHX
- LXEO
- Stock Information
- Founded
- PHX 1926
- LXEO 2017
- Country
- PHX United States
- LXEO United States
- Employees
- PHX N/A
- LXEO N/A
- Industry
- PHX Oil & Gas Production
- LXEO
- Sector
- PHX Energy
- LXEO
- Exchange
- PHX Nasdaq
- LXEO Nasdaq
- Market Cap
- PHX 150.9M
- LXEO 154.0M
- IPO Year
- PHX N/A
- LXEO 2023
- Fundamental
- Price
- PHX $4.34
- LXEO $3.18
- Analyst Decision
- PHX
- LXEO Strong Buy
- Analyst Count
- PHX 0
- LXEO 5
- Target Price
- PHX N/A
- LXEO $20.20
- AVG Volume (30 Days)
- PHX 396.8K
- LXEO 984.1K
- Earning Date
- PHX 05-08-2025
- LXEO 05-12-2025
- Dividend Yield
- PHX 3.69%
- LXEO N/A
- EPS Growth
- PHX 71.86
- LXEO N/A
- EPS
- PHX 0.19
- LXEO N/A
- Revenue
- PHX $36,087,715.00
- LXEO N/A
- Revenue This Year
- PHX $30.25
- LXEO N/A
- Revenue Next Year
- PHX $4.76
- LXEO N/A
- P/E Ratio
- PHX $22.86
- LXEO N/A
- Revenue Growth
- PHX 16.59
- LXEO N/A
- 52 Week Low
- PHX $3.09
- LXEO $1.45
- 52 Week High
- PHX $4.24
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- PHX 64.36
- LXEO 46.61
- Support Level
- PHX $3.53
- LXEO $2.43
- Resistance Level
- PHX $3.97
- LXEO $3.11
- Average True Range (ATR)
- PHX 0.09
- LXEO 0.59
- MACD
- PHX 0.06
- LXEO -0.11
- Stochastic Oscillator
- PHX 98.77
- LXEO 16.03
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.